Drug profile

The FDA adverse-event record for Reglan

24 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Reglan. Species, reactions, and outcomes follow.

#1632 of 2,679
by report volume (all drugs)
24
adverse-event reports
41.7%
death-coded share
Dog
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Reglan ranks #1609 of 2679 by total reports (24). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#1609
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Reglan has 24 reports now versus 24 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Reglan changes

Signature read: Reglan's 41.7% death-coded share is among the highest in the openFDA drug corpus.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
24
Total Reports
10
Deaths Reported
41.7%
Death-coded share of reports

Active Ingredients

Reglan

Administration Routes

UnknownOralParenteralSubcutaneousIntravenous

Species Affected

Dog 23
Cat 1

Most Affected Breeds

Crossbred Canine/dog 3
Retriever - Golden 3
Dog (unknown) 2
Terrier - Boston 2
Chow Chow 2
Poodle - Miniature 1
Shepherd Dog - Australian 1
Spaniel - Cocker American 1
Domestic Shorthair 1
Pinscher - Miniature 1

Most Reported Reactions

Anorexia 8
Death by euthanasia 7
Diarrhoea 6
Lethargy (see also Central nervous system depression in Neurological) 6
Vomiting 4
Elevated blood urea nitrogen (BUN) 4
Ataxia 4
Other abnormal test result NOS 3
Hypoalbuminaemia 3
Death 3
Urinary incontinence 3
Bloody diarrhoea 3

Outcome Breakdown

Euthanized
6 (25.0%)
Ongoing
6 (25.0%)
Outcome Unknown
5 (20.8%)
Died
4 (16.7%)
Recovered/Normal
3 (12.5%)

Reglan: high death-coded share in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Reglan (#1632 of 2,679 by report volume); death-coded 41.7%. PlainBreed drug row · death-coded share stamp 41.7% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →